Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs | Zendy

Liv Guro Engen Hanem | Zendy; Solhild Stridsklev | Zendy; Pétur Benedikt Júlíusson | Zendy; Øyvind Salvesen | Zendy; Mathieu Roelants | Zendy; Sven M. Carlsen | Zendy; Rønnaug Ødegård | Zendy; Eszter Vanky | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs

Author(s) -

Liv Guro Engen Hanem,

Solhild Stridsklev,

Pétur Benedikt Júlíusson,

Øyvind Salvesen,

Mathieu Roelants,

Sven M. Carlsen,

Rønnaug Ødegård,

Eszter Vanky

Publication year - 2018

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2017-02419

Subject(s) - medicine , overweight , metformin , body mass index , polycystic ovary , placebo , odds ratio , obstetrics , pregnancy , gestational diabetes , confidence interval , randomized controlled trial , obesity , waist , gynecology , diabetes mellitus , gestation , endocrinology , insulin resistance , alternative medicine , pathology , biology , genetics

Metformin is used in pregnancy in women with gestational diabetes mellitus, polycystic ovary syndrome (PCOS), and obesity. Metformin passes the placenta.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research